PhorMed Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
PhorMed is at the forefront of biotechnology innovation with our flagship pharmaceutical agent, designated as RP-323. We are working to utilize gene therapy to treat diseases, allowing the body to heal and giving new hope to patients suffering from diseases like AML, Hodgkin’s Lymphoma, ARDS, Parkinson’s disease, and viruses.